We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Formulatrix Announces Licensing Agreement

News   Nov 02, 2005

 
Formulatrix Announces Licensing Agreement
 
 
 

RELATED ARTICLES

New Libido Drug Vyleesi Approved to Treat Hypoactive Sexual Desire in Women

News

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

READ MORE

Wave Goodbye to Weights as We Know Them

News

Following the General Conference on Weights and Measures in November 2018, perhaps one of the most significant revisions to the International System of Units (the SI) since its inception was agreed. Today, on World Metrology Day, it is being put into action.

READ MORE

Designing “Smart” Drugs to Prevent Malaria Treatment Resistance

News

Researchers at the Crick and Imperial College London have generated malaria parasites resistant to a promising new class of candidate antimalarial drugs. By analyzing the structural changes behind the resistance, they identified novel compounds that were immune to this mechanism of resistance.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE